CIK 0001191070 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Neuphoria Therapeutics Inc.
Sign in to watch- Ticker
- NEUP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- operating
- Phone
- 781-439-5551
- Business address
- 100 SUMMIT DR, BURLINGTON, MA, 01803
- Former names
- BIONOMICS LIMITED/FI
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFA14A Proxy Proxy Materials
- PREC14A Other PREC14A
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 424B5 Offering Prospectus
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 424B5 Offering Prospectus
- 8-K Event Other events
- 10-K Report Annual Report
- 424B5 Offering Prospectus
- 8-K Event Delisting notice
- 4 Insider Changes in Ownership
Page 3 of 21 · 420 filings